Amedeo Smart

Free Medical Literature Service

 

Amedeo

Leukemia
  Free Subscription

Articles published in
N Engl J Med
    October 2026
  1. CHIARETTI S, Piciocchi A, Skert C, Leoncin M, et al
    Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.
    N Engl J Med. 2026;395:1483-1494.
    >> Share

    September 2026
  2. MYERS RM, Hunger SP
    Blinatumomab - A New Standard of Care in Acute Lymphoblastic Leukemia.
    N Engl J Med. 2026;395:1127-1129.
    >> Share

  3. SCHRAPPE M, Locatelli F, Valsecchi MG, Zugmaier G, et al
    Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.
    N Engl J Med. 2026;395:1075-1089.
    >> Share

  4. FATHI AT, Perl AE, Fell GG, Jonas BA, et al
    Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.
    N Engl J Med. 2026;395:845-858.
    >> Share

    June 2026
  5. ANNAMALAY A, Radich J
    Chronic Myeloid Leukemia in Low- and Middle-Income Countries. Reply.
    N Engl J Med. 2026;394:2175-2176.
    >> Share

  6. MAHON FX, Rea D, Rousselot P
    Chronic Myeloid Leukemia in Low- and Middle-Income Countries.
    N Engl J Med. 2026;394:2175.
    >> Share

  7. ROBOZ GJ, Zeidan AM, Mannis GN, Montesinos P, et al
    All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.
    N Engl J Med. 2026;394:2107-2116.
    >> Share

    March 2026
  8. ANNAMALAY A, Garcia Gonzalez I, Forsyth C, Jenkins I, et al
    Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries.
    N Engl J Med. 2026;394:1238-1240.
    >> Share

    December 2025
  9. CHIESA R, Georgiadis C, Rashed H, Preece R, et al
    Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.
    N Engl J Med. 2025 Dec 8. doi: 10.1056/NEJMoa2505478.
    >> Share

  10. AL-SAWAF O, Stumpf J, Zhang C, Simon F, et al
    Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.
    N Engl J Med. 2025 Dec 6. doi: 10.1056/NEJMoa2515458.
    >> Share

  11. MUNIR T, Cairns DA, Hillmen P
    Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia. Reply.
    N Engl J Med. 2025;393:2280.
    >> Share

  12. WANG Y, Zhu Z, Liang Y
    Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
    N Engl J Med. 2025;393:2279-2280.
    >> Share

  13. FLEISCHMAN RA
    Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
    N Engl J Med. 2025;393:2279.
    >> Share

    June 2025
  14. MUNIR T, Girvan S, Cairns DA, Bloor A, et al
    Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
    N Engl J Med. 2025 Jun 15. doi: 10.1056/NEJMoa2504341.
    >> Share

  15. GUPTA S, Rau RE, Loh ML
    Blinatumomab in Childhood B-Cell Acute Lymphoblastic Leukemia. Reply.
    N Engl J Med. 2025;392:2286-2287.
    >> Share

  16. HODDER A, Vora A, Samarasinghe S
    Blinatumomab in Childhood B-Cell Acute Lymphoblastic Leukemia.
    N Engl J Med. 2025;392:2286.
    >> Share

  17. BROWN JR, Miller K, Munugalavadla V
    Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia. Reply.
    N Engl J Med. 2025;392:2181.
    >> Share

  18. MOHTY M, Kharfan-Dabaja MA
    Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
    N Engl J Med. 2025;392:2180-2181.
    >> Share

    May 2025
  19. FOA R
    Ph-Positive Acute Lymphoblastic Leukemia - 25 Years of Progress.
    N Engl J Med. 2025;392:1941-1952.
    >> Share

    April 2025
  20. SANTI A, Venanzi A, Pucciarini A, Schiavoni G, et al
    Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.
    N Engl J Med. 2025;392:1451-1452.
    >> Share

    February 2025
  21. BROWN JR, Seymour JF, Jurczak W, Aw A, et al
    Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
    N Engl J Med. 2025;392:748-762.
    >> Share

    January 2025
  22. BASHIR BA
    Chronic Myeloid Leukemia with Hyperleukocytosis.
    N Engl J Med. 2025;392:72.
    >> Share

    December 2024
  23. FALINI B, Tiacci E
    Hairy-Cell Leukemia. Reply.
    N Engl J Med. 2024;391:2388.
    >> Share

  24. HERMEL DJ, Saven A
    Hairy-Cell Leukemia.
    N Engl J Med. 2024;391:2387-2388.
    >> Share

  25. REINHOLD I, Cornely OA, Stemler J
    Hairy-Cell Leukemia.
    N Engl J Med. 2024;391:2386-2387.
    >> Share

  26. ABRUZZESE E
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. Reply.
    N Engl J Med. 2024;391:2276.
    >> Share

  27. HOCHHAUS A, Cortes JE, Hughes TP
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. Reply.
    N Engl J Med. 2024;391:2275-2276.
    >> Share

  28. PUNWANI N
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
    N Engl J Med. 2024;391:2275.
    >> Share

  29. GAMBACORTI-PASSERINI C, Piazza R
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
    N Engl J Med. 2024;391:2274-2275.
    >> Share

  30. GUPTA S, Rau RE, Kairalla JA, Rabin KR, et al
    Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
    N Engl J Med. 2024 Dec 7. doi: 10.1056/NEJMoa2411680.
    >> Share

    November 2024
  31. RODDIE C, Sandhu KS, Tholouli E, Logan AC, et al
    Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia.
    N Engl J Med. 2024 Nov 27. doi: 10.1056/NEJMoa2406526.
    >> Share

    October 2024
  32. FALINI B, Tiacci E
    Hairy-Cell Leukemia.
    N Engl J Med. 2024;391:1328-1341.
    >> Share

    September 2024
  33. ABRUZZESE E
    CML 25 Years Later - Poised for Another Breakthrough?
    N Engl J Med. 2024;391:955-957.
    >> Share

    August 2024
  34. HSU C, Konner JA, Gounder MM
    Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword.
    N Engl J Med. 2024;391:770-772.
    >> Share

    July 2024
  35. LITZOW MR, Sun Z, Mattison RJ, Paietta EM, et al
    Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
    N Engl J Med. 2024;391:320-333.
    >> Share

    June 2024
  36. TIONG IS, Ritchie DS, Blombery P
    Response and Resistance to Menin Inhibitor in UBTF-Tandem Duplication AML.
    N Engl J Med. 2024;390:2323-2325.
    >> Share

    May 2024
  37. HOCHHAUS A, Wang J, Kim DW, Kim DDH, et al
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
    N Engl J Med. 2024 May 31. doi: 10.1056/NEJMoa2400858.
    >> Share

  38. MUNIR T, Hillmen P
    Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. Reply.
    N Engl J Med. 2024;390:1634-1635.
    >> Share

  39. WANG WD, Gale RP, Liang Y
    Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
    N Engl J Med. 2024;390:1633-1634.
    >> Share

  40. WINKLER C
    Acute Promyelocytic Leukemia.
    N Engl J Med. 2024;390:e42.
    >> Share

    April 2024
  41. BLAISE D
    CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia.
    N Engl J Med. 2024;390:1526-1527.
    >> Share

  42. HU Y, Zhang M, Yang T, Mo Z, et al
    Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
    N Engl J Med. 2024;390:1467-1480.
    >> Share

    December 2023
  43. MUNIR T, Cairns DA, Bloor A, Allsup D, et al
    Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
    N Engl J Med. 2023 Dec 10. doi: 10.1056/NEJMoa2310063.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016